In Egypt, a recent comparative study evaluating NAT and serological screening reported HBV reactivity of approximately 710 per 100,000, HCV at 1,520 per 100,000, and HIV at 20 per 100,000; values notably higher than those observed in Gulf countries and reflecting Egypt’s well-documented burden of viral hepatitis (27). The gene discussed is BRD2; the disease is viral hepatitis.